Physician profile
Barry I Stein
NPI 1609865609
$10,843.96
in general payments reported to CMS, 2019-2025
58 companies · $1,319 in 2025
The $1,319 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,675 · 2020: $907 · 2021: $1,042 · 2022: $1,727 · 2023: $2,233 · 2024: $1,941 · 2025: $1,319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,480 · Entertainment: $13.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,480.12 |
| Entertainment | $13.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,207.47 | 2019-2025 | Ubrelvy, Vraylar, Synthroid |
| Pfizer INC. | $1,075.11 | 2019-2025 | |
| Lilly USA, LLC | $860.98 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Novo Nordisk INC | $754.28 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $698.09 | 2021-2025 | |
| Amgen INC. | $623.49 | 2019-2025 | Repatha, Otezla, Repatha |
| Glaxosmithkline, LLC. | $571.58 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Merck Sharp & Dohme LLC | $559.70 | 2019-2023 | Verquvo, Belsomra, Januvia |
| Sumitomo Pharma America, INC. | $546.69 | 2023-2025 | Gemtesa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $446.01 | 2019-2025 | Jardiance, Synjardy |
| Astrazeneca Pharmaceuticals Lp | $381.75 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Exact Sciences Corporation | $294.13 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astellas Pharma US INC | $226.61 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $208.93 | 2019-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $179.36 | 2019-2025 |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $178.78 | 2019-2022 | |
| Ibsa Pharma INC. | $171.28 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $160.81 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $144.88 | 2019-2025 | Xifaxan |
| Biohaven Pharmaceuticals, INC. | $123.04 | 2021 | |
| Dexcom, INC. | $106.60 | 2021-2025 | Dexcom G6 Transmitter |
| Biohaven Pharmaceutical Holding Company Ltd. | $90.89 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $87.96 | 2022-2024 | Rexulti |
| Hologic Sales and Service, LLC | $73.66 | 2023-2024 | Aptima, Thinprep 2000 Processor |
| Boston Scientific Corporation | $64.48 | 2020-2024 | Watchman Access System |
| Halozyme INC | $62.23 | 2023 | |
| Antares Pharma, INC. | $59.19 | 2019-2022 | |
| Daiichi Sankyo INC. | $57.63 | 2019-2024 | Injectafer |
| Lundbeck LLC | $56.66 | 2023-2024 | Rexulti |
| Shionogi INC | $53.71 | 2021-2022 | |
| Amarin Pharma, INC. | $51.69 | 2019-2021 | |
| Acadia Pharmaceuticals INC | $49.31 | 2025 | Daybue |
| Idorsia Pharmaceuticals US INC | $45.63 | 2022-2023 | Quviviq |
| Xeris Pharmaceuticals, INC. | $44.10 | 2022-2024 | Keveyis |
| Centinel Spine, LLC | $38.50 | 2021 | |
| Abbott Laboratories | $37.69 | 2023 | Freestyle Libre 2, Freestyle Libre 3 |
| Genentech USA, INC. | $33.41 | 2019-2020 | |
| Radius Health, INC. | $31.84 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $29.81 | 2022-2023 | Eliquis |
| Harmony Biosciences LLC | $29.66 | 2020 | |
| Shire North American Group INC | $29.14 | 2019 | |
| Ironwood Pharmaceuticals, INC | $24.97 | 2020 | |
| Bausch Health US, LLC | $24.93 | 2025 | Aplenzin, Wellbutrin |
| Teva Pharmaceuticals USA, INC. | $22.57 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $20.99 | 2023 | Evkeeza |
| Horizon Therapeutics Plc | $20.85 | 2023 | Krystexxa |
| Cranial Technologies, INC | $20.80 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.72 | 2019 | |
| Ge Healthcare | $17.46 | 2019 | |
| Almatica Pharma LLC | $17.07 | 2023 | Sertraline Hcl, Loreev Xr, Gralise |
| Paratek Pharmaceuticals, INC. | $16.55 | 2024 | Nuzyra |
| Allergan, INC. | $15.29 | 2020 | |
| Nevro Corp. | $15.02 | 2024 | Senza |
| Phathom Pharmaceuticals, INC. | $14.92 | 2025 | Voquezna |
| Eisai INC. | $13.39 | 2021 | |
| Optos, INC. | $13.24 | 2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Pharming Healthcare, INC. | $11.59 | 2021 | |
| Clarus Therapeutics INC. | $9.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Stein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.